 "Apollo Hospitals has been investing big in infrastructure and bringing in advanced technologies such as Proton Therapy for cancer treatment, which has resulted in a higher debt")
The CSIR-Centre for Cellular & Molecular Biology (CCMB) and Apollo Hospitals Enterprise on Thursday announced a collaboration for joint manufacturing and commercialisation of a test to detect Covid-19.
The Direct Amplification rapid RT-PCR (DArRT-PCR) test allows for rapid, safer and more cost-effective testing. The biological sample can be directly isolated from patients' swabs and it uses a one-step protocol. “The virus will be here for some time, it seems, and those who test more frequently will be able to contain the impact of Covid-19 better. Cheaper, rapid and easy to use tests as these are the need of the hour. With
